The Stereotypic Response of the Pulmonary Vasculature to Respiratory Viral Infections: Findings in Mouse Models of SARS-CoV-2, Influenza A and Gammaherpesvirus Infections.

influenza A virus lung mouse models murine gammaherpesvirus 68 severe acute respiratory syndrome coronavirus 2 vasculitis

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
27 07 2023
Historique:
received: 19 06 2023
revised: 14 07 2023
accepted: 24 07 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

The respiratory system is the main target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 19 (COVID-19) where acute respiratory distress syndrome is considered the leading cause of death. Changes in pulmonary blood vessels, among which an endothelialitis/endotheliitis has been particularly emphasized, have been suggested to play a central role in the development of acute lung injury. Similar vascular changes are also observed in animal models of COVID-19. The present study aimed to determine whether the latter are specific for SARS-CoV-2 infection, investigating the vascular response in the lungs of mice infected with SARS-CoV-2 and other respiratory viruses (influenza A and murine gammaherpesvirus) by in situ approaches (histology, immunohistology, morphometry) combined with RNA sequencing and bioinformatic analysis. Non-selective recruitment of monocytes and T and B cells from larger muscular veins and arteries was observed with all viruses, matched by a comparable transcriptional response. There was no evidence of endothelial cell infection in any of the models. Both the morphological investigation and the transcriptomics approach support the interpretation that the lung vasculature in mice mounts a stereotypic response to alveolar and respiratory epithelial damage. This may have implications for the treatment and management of respiratory disease in humans.

Identifiants

pubmed: 37631979
pii: v15081637
doi: 10.3390/v15081637
pmc: PMC10458810
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/W005611/1
Pays : United Kingdom

Références

Cell Tissue Res. 2014 Mar;355(3):647-56
pubmed: 24562377
Lancet Respir Med. 2021 Jun;9(6):622-642
pubmed: 33965003
Viruses. 2022 Jun 27;14(7):
pubmed: 35891384
Am J Pathol. 2021 Aug;191(8):1374-1384
pubmed: 34033751
Nat Rev Immunol. 2007 Sep;7(9):678-89
pubmed: 17717539
Sci Adv. 2022 Sep 23;8(38):eabo6783
pubmed: 36129989
Theranostics. 2021 Jul 6;11(16):8076-8091
pubmed: 34335981
Virchows Arch. 2021 Jan;478(1):137-150
pubmed: 33604758
Mod Pathol. 2005 Jan;18(1):1-10
pubmed: 15272286
Front Immunol. 2021 Aug 16;12:691957
pubmed: 34484188
Lancet. 2020 Aug 1;396(10247):320-332
pubmed: 32682491
Viruses. 2022 Mar 05;14(3):
pubmed: 35336942
Lancet Respir Med. 2022 Jan;10(1):95-106
pubmed: 34871544
Physiol Rev. 2003 Apr;83(2):309-36
pubmed: 12663861
EBioMedicine. 2020 Nov;61:103104
pubmed: 33158808
Vet Pathol. 2013 Jan;50(1):7-22
pubmed: 23345459
Vet Pathol. 2022 Jul;59(4):613-626
pubmed: 34955064
Nature. 2021 May;593(7857):142-146
pubmed: 33780970
Respiration. 2022;101(2):155-165
pubmed: 34525475
Pediatr Clin North Am. 2022 Dec;69(6):1199-1217
pubmed: 36880930
J Virol. 2010 Apr;84(8):3949-61
pubmed: 20130062
FEBS Lett. 2021 Sep;595(18):2323-2340
pubmed: 34331769
Am J Pathol. 2011 Jun;178(6):2560-72
pubmed: 21641381
Am J Respir Crit Care Med. 2021 Jan 15;203(2):192-201
pubmed: 33217246
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Viruses. 2021 Nov 11;13(11):
pubmed: 34835069
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Cell. 2020 Nov 25;183(5):1354-1366.e13
pubmed: 33065030
Semin Diagn Pathol. 2017 Nov;34(6):510-517
pubmed: 28693907
Brain Pathol. 2020 Nov;30(6):1012-1016
pubmed: 32762083
Arch Ophtalmol Rev Gen Ophtalmol. 1958 Apr-May;18(3):262-93
pubmed: 13560109
J Pathol. 2003 Jul;200(3):282-9
pubmed: 12845623
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Viruses. 2021 Apr 08;13(4):
pubmed: 33918079
EBioMedicine. 2021 Jan;63:103182
pubmed: 33422990
Lancet. 2022 Jan 15;399(10321):234-236
pubmed: 34942101
Neuropathol Appl Neurobiol. 2021 Apr;47(3):454-459
pubmed: 33249605
Cell Adh Migr. 2013 Jan-Feb;7(1):101-10
pubmed: 23263631
PLoS One. 2017 Apr 11;12(4):e0175188
pubmed: 28399143
Ophthalmol Ther. 2019 Jun;8(2):195-213
pubmed: 30859513
Cell Mol Life Sci. 2021 May;78(9):4095-4124
pubmed: 33544156
Mod Pathol. 2007 Jan;20(1):108-19
pubmed: 17143259
J Infect Dis. 2020 Oct 1;222(9):1462-1467
pubmed: 32798217
Lancet. 2020 May 30;395(10238):e99
pubmed: 32442529
Lancet. 2020 Oct 31;396(10260):e64-e65
pubmed: 33031763
Int J Biochem Cell Biol. 2020 Oct;127:105823
pubmed: 32781135
Virchows Arch. 2020 Sep;477(3):349-357
pubmed: 32607684
Biochem Pharmacol. 2022 Mar;197:114909
pubmed: 35021044
Mucosal Immunol. 2022 May;15(5):952-963
pubmed: 35840680
Immunol Cell Biol. 2013 Apr;91(4):281-9
pubmed: 23337698
Mucosal Immunol. 2018 Jan;11(1):71-81
pubmed: 28513596
Vet Pathol. 2022 Jul;59(4):661-672
pubmed: 35001763
N Engl J Med. 2020 Sep 3;383(10):989-992
pubmed: 32530583
Nephron. 1980;26(6):296-300
pubmed: 7453917
Am Fam Physician. 2019 Dec 15;100(12):751-758
pubmed: 31845781
Virchows Arch. 2022 Aug;481(2):139-159
pubmed: 35364700
Viruses. 2022 May 11;14(5):
pubmed: 35632761
Front Immunol. 2021 Apr 12;12:640842
pubmed: 33912167
Immunity. 2014 Nov 20;41(5):694-707
pubmed: 25517612
PLoS One. 2017 Jun 2;12(6):e0178408
pubmed: 28575086
Viruses. 2020 Jul 20;12(7):
pubmed: 32698441
Hepatology. 1984 Jan-Feb;4(1):123-30
pubmed: 6363248

Auteurs

Simon De Neck (S)

Laboratory for Animal Model Pathology, Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zurich, 8057 Zurich, Switzerland.

Rebekah Penrice-Randal (R)

Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.

Jordan J Clark (JJ)

Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.

Parul Sharma (P)

Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.

Eleanor G Bentley (EG)

Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.

Adam Kirby (A)

Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.

Daniele F Mega (DF)

Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.

Ximeng Han (X)

Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.

Andrew Owen (A)

Centre of Excellence in Long-Acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L3 3RF, UK.

Julian A Hiscox (JA)

Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.

James P Stewart (JP)

Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.

Anja Kipar (A)

Laboratory for Animal Model Pathology, Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zurich, 8057 Zurich, Switzerland.
Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK.
Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, University of Helsinki, 00790 Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH